These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15452412)

  • 1. Molecular analysis of the effect of topical imiquimod treatment of HPV 2/27/57-induced common warts.
    Jacobs S; Grussendorf-Conen EI; Rösener I; Rübben A
    Skin Pharmacol Physiol; 2004; 17(5):258-66. PubMed ID: 15452412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
    Arany I; Tyring SK; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
    Antiviral Res; 1999 Aug; 43(1):55-63. PubMed ID: 10480263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plantar wart treatment with combination imiquimod and salicylic acid pads.
    Tucker SB; Ali A; Ransdell BL
    J Drugs Dermatol; 2003 Jan; 2(1):70-2. PubMed ID: 12852385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plantar wart treatment with combination imiquimod and salicylic acid pads.
    Tucker SB; Ali A; Ransdell BL
    J Drugs Dermatol; 2003 Apr; 2(2):124-6. PubMed ID: 12905977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
    Grussendorf-Conen EI; Jacobs S
    Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of non-genital warts with topical imiquimod 5% cream.
    Muzio G; Massone C; Rebora A
    Eur J Dermatol; 2002; 12(4):347-9. PubMed ID: 12095879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.
    Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
    J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
    J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities.
    Grussendorf-Conen EI; Jacobs S; Rübben A; Dethlefsen U
    Dermatology; 2002; 205(2):139-45. PubMed ID: 12218229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream.
    Juschka U; Hartmann M
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():48-50. PubMed ID: 14616816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
    Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
    Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plantar warts treated with an immune response modifier: a report of two cases.
    Zamiri M; Gupta G
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():45-7. PubMed ID: 14616815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463.
    Imbertson LM; Beaurline JM; Couture AM; Gibson SJ; Smith RM; Miller RL; Reiter MJ; Wagner TL; Tomai MA
    J Invest Dermatol; 1998 May; 110(5):734-9. PubMed ID: 9579537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
    Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
    Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional Laser-Assisted Topical Imiquimod 5% Cream Treatment for Recalcitrant Common Warts in Children: A Pilot Study.
    Park SM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
    Dermatol Surg; 2016 Dec; 42(12):1340-1346. PubMed ID: 27598444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical imiquimod for recalcitrant facial flat warts.
    Schwab RA; Elston DM
    Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using imiquimod for genital warts in female patients.
    Cox JT; Petry KU; Rylander E; Roy M
    J Womens Health (Larchmt); 2004 Apr; 13(3):265-71. PubMed ID: 15130255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
    Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
    Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.